Is there a generic for Prazosin hydrochloride?

Yes. The FDA Orange Book lists 23 approved generic (ANDA) applications for Prazosin hydrochloride, referencing the brand MINIPRESS. Generics rated with an "A" therapeutic-equivalence code are considered substitutable for the brand.

What is the reference-listed drug for Prazosin hydrochloride?

MINIPRESS (NDA 017442, PFIZER) is the reference-listed drug — the approved product a generic applicant must show its version is the same as.

What dosage forms of Prazosin hydrochloride are approved?

Prazosin hydrochloride is approved in the following dosage forms: capsule, tablet, extended release.

FDA Orange Book · active-ingredient family

Prazosin hydrochloride

Prazosin hydrochloride: 2 brands, 23 generics; first approved Sep 12, 1988; generic available.

Generic availableHas discontinued products

Generic status & protection

Generic available — 23 ANDA applications approved.

Brands (NDA)

Generics (ANDA)

Listed patents

Presentations

Originator applications

Brand (NDA) products

MINIPRESSRLD

PFIZERNDA 017442—3 strengths

Approved strengths under this FDA application.
Strength	Dosage form	Route	Status	TE
EQ 5MG BASE	CAPSULE	ORAL	Rx	AB
EQ 1MG BASE	CAPSULE	ORAL	Rx	AB
EQ 2MG BASE	CAPSULE	ORAL	Rx	AB

MINIPRESS XL

PFIZERNDA 01977519922 strengths

Approved strengths under this FDA application.
Strength	Dosage form	Route	Status	TE
2.5MG	TABLET, EXTENDED RELEASE	ORAL	Discontinued	—
5MG	TABLET, EXTENDED RELEASE	ORAL	Discontinued	—

Abbreviated applications

Generic (ANDA) products (23)

PRAZOSIN HYDROCHLORIDE

MSNANDA 21672720243 strengths

Approved strengths under this FDA application.
Strength	Dosage form	Route	Status	TE
EQ 1MG BASE	CAPSULE	ORAL	Rx	AB
EQ 2MG BASE	CAPSULE	ORAL	Rx	AB
EQ 5MG BASE	CAPSULE	ORAL	Rx	AB

PRAZOSIN HYDROCHLORIDE

LANNETT CO INCANDA 21408320243 strengths

Approved strengths under this FDA application.
Strength	Dosage form	Route	Status	TE
EQ 1MG BASE	CAPSULE	ORAL	Discontinued	—
EQ 2MG BASE	CAPSULE	ORAL	Discontinued	—
EQ 5MG BASE	CAPSULE	ORAL	Discontinued	—

PRAZOSIN HYDROCHLORIDE

AUROBINDO PHARMA LTDANDA 21305220233 strengths

Approved strengths under this FDA application.
Strength	Dosage form	Route	Status	TE
EQ 1MG BASE	CAPSULE	ORAL	Rx	AB
EQ 2MG BASE	CAPSULE	ORAL	Rx	AB
EQ 5MG BASE	CAPSULE	ORAL	Rx	AB

PRAZOSIN HYDROCHLORIDE

ALEMBICANDA 21726820233 strengths

Approved strengths under this FDA application.
Strength	Dosage form	Route	Status	TE
EQ 1MG BASE	CAPSULE	ORAL	Rx	AB
EQ 2MG BASE	CAPSULE	ORAL	Rx	AB
EQ 5MG BASE	CAPSULE	ORAL	Rx	AB

PRAZOSIN HYDROCHLORIDE

MANKIND PHARMAANDA 21569720223 strengths

Approved strengths under this FDA application.
Strength	Dosage form	Route	Status	TE
EQ 1MG BASE	CAPSULE	ORAL	Rx	AB
EQ 2MG BASE	CAPSULE	ORAL	Rx	AB
EQ 5MG BASE	CAPSULE	ORAL	Rx	AB

PRAZOSIN HYDROCHLORIDE

APPCOANDA 21340620223 strengths

Approved strengths under this FDA application.
Strength	Dosage form	Route	Status	TE
EQ 1MG BASE	CAPSULE	ORAL	Rx	AB
EQ 2MG BASE	CAPSULE	ORAL	Rx	AB
EQ 5MG BASE	CAPSULE	ORAL	Rx	AB

PRAZOSIN HYDROCHLORIDE

GRANULESANDA 21460820213 strengths

Approved strengths under this FDA application.
Strength	Dosage form	Route	Status	TE
EQ 1MG BASE	CAPSULE	ORAL	Rx	AB
EQ 2MG BASE	CAPSULE	ORAL	Rx	AB
EQ 5MG BASE	CAPSULE	ORAL	Rx	AB

PRAZOSIN HYDROCHLORIDE

NOVITIUM PHARMAANDA 21097120183 strengths

Approved strengths under this FDA application.
Strength	Dosage form	Route	Status	TE
EQ 1MG BASE	CAPSULE	ORAL	Rx	AB
EQ 2MG BASE	CAPSULE	ORAL	Rx	AB
EQ 5MG BASE	CAPSULE	ORAL	Rx	AB

PRAZOSIN HYDROCHLORIDE

AM THERAPANDA 0727821989

Approved strengths under this FDA application.
Strength	Dosage form	Route	Status	TE
EQ 1MG BASE	CAPSULE	ORAL	Discontinued	—

PRAZOSIN HYDROCHLORIDE

AM THERAPANDA 0727831989

Approved strengths under this FDA application.
Strength	Dosage form	Route	Status	TE
EQ 2MG BASE	CAPSULE	ORAL	Discontinued	—

PRAZOSIN HYDROCHLORIDE

AM THERAPANDA 0727841989

Approved strengths under this FDA application.
Strength	Dosage form	Route	Status	TE
EQ 5MG BASE	CAPSULE	ORAL	Discontinued	—

PRAZOSIN HYDROCHLORIDE

ANI PHARMSANDA 07257719893 strengths

Approved strengths under this FDA application.
Strength	Dosage form	Route	Status	TE
EQ 2MG BASE	CAPSULE	ORAL	Discontinued	—
EQ 1MG BASE	CAPSULE	ORAL	Discontinued	—
EQ 5MG BASE	CAPSULE	ORAL	Discontinued	—

PRAZOSIN HYDROCHLORIDE

DAVA PHARMS INCANDA 0727051989

Approved strengths under this FDA application.
Strength	Dosage form	Route	Status	TE
EQ 1MG BASE	CAPSULE	ORAL	Discontinued	—

PRAZOSIN HYDROCHLORIDE

DAVA PHARMS INCANDA 0727061989

Approved strengths under this FDA application.
Strength	Dosage form	Route	Status	TE
EQ 2MG BASE	CAPSULE	ORAL	Discontinued	—

PRAZOSIN HYDROCHLORIDE

DAVA PHARMS INCANDA 0727071989

Approved strengths under this FDA application.
Strength	Dosage form	Route	Status	TE
EQ 5MG BASE	CAPSULE	ORAL	Discontinued	—

PRAZOSIN HYDROCHLORIDE

MYLANANDA 07257519893 strengths

Approved strengths under this FDA application.
Strength	Dosage form	Route	Status	TE
EQ 5MG BASE	CAPSULE	ORAL	Rx	AB
EQ 2MG BASE	CAPSULE	ORAL	Rx	AB
EQ 1MG BASE	CAPSULE	ORAL	Rx	AB

PRAZOSIN HYDROCHLORIDE

PUREPAC PHARMANDA 0729911989

Approved strengths under this FDA application.
Strength	Dosage form	Route	Status	TE
EQ 1MG BASE	CAPSULE	ORAL	Discontinued	—

PRAZOSIN HYDROCHLORIDE

PUREPAC PHARMANDA 0729211989

Approved strengths under this FDA application.
Strength	Dosage form	Route	Status	TE
EQ 2MG BASE	CAPSULE	ORAL	Discontinued	—

PRAZOSIN HYDROCHLORIDE

PUREPAC PHARMANDA 0729921989

Approved strengths under this FDA application.
Strength	Dosage form	Route	Status	TE
EQ 5MG BASE	CAPSULE	ORAL	Discontinued	—

PRAZOSIN HYDROCHLORIDE

WATSON LABSANDA 0723521989

Approved strengths under this FDA application.
Strength	Dosage form	Route	Status	TE
EQ 1MG BASE	CAPSULE	ORAL	Discontinued	—

PRAZOSIN HYDROCHLORIDE

WATSON LABSANDA 0723331989

Approved strengths under this FDA application.
Strength	Dosage form	Route	Status	TE
EQ 2MG BASE	CAPSULE	ORAL	Discontinued	—

PRAZOSIN HYDROCHLORIDE

WATSON LABSANDA 0726091989

Approved strengths under this FDA application.
Strength	Dosage form	Route	Status	TE
EQ 5MG BASE	CAPSULE	ORAL	Discontinued	—

PRAZOSIN HYDROCHLORIDE

TEVA PHARMSANDA 07174519883 strengths

Approved strengths under this FDA application.
Strength	Dosage form	Route	Status	TE
EQ 5MG BASE	CAPSULE	ORAL	Rx	AB
EQ 1MG BASE	CAPSULE	ORAL	Rx	AB
EQ 2MG BASE	CAPSULE	ORAL	Rx	AB

Orange Book patent file

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

FDA approval span

Approval history

First approval

Sep 12, 1988

38 yr 5 mo ago

Most recent approval

Sep 17, 2024

1 yr 10 mo ago

Approvals span 1988–2024 across 25 FDA applications.

Brand (NDA) 28%

Generic (ANDA) 2392%

Prazosin hydrochloride — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Built directly from the FDA Orange Book data file (products, patents, and exclusivity). TE codes, RLD/RS flags, patent expirations, and exclusivity dates match the official FDA record. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Related FDA reference tools

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo